West Pharmaceutical Services (WST) Debt Ratio (2009 - 2026)

West Pharmaceutical Services has disclosed Debt Ratio across 18 years of filings, most recently posting 0.05 for Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.05, down 11.87% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.05 (down 11.87% YoY), and the FY2025 annual result was 0.05, down 14.59% from the prior year.
• Debt Ratio came in at 0.05 for Q1 2026 at West Pharmaceutical Services, up from 0.05 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.06 in Q1 2022 to a low of 0.02 in Q4 2023.
• The 5-year median for Debt Ratio is 0.06 (2024), against an average of 0.05.
• Across the five-year window, Debt Ratio plunged 66.74% in 2023 and jumped 192.51% in 2024, its largest moves.
• West Pharmaceutical Services' Debt Ratio stood at 0.06 in 2022, then slumped by 66.74% to 0.02 in 2023, then jumped by 192.51% to 0.06 in 2024, then fell by 14.59% to 0.05 in 2025, then increased by 3.9% to 0.05 in 2026.
• The last three Debt Ratio figures came in at 0.05 (Q1 2026), 0.05 (Q4 2025), and 0.05 (Q3 2025), per Business Quant data.